NovoCure Ltd — Director's Dealing 2026

Mar 3, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2026-02-27

Reporting Person: Cordova Ashley (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-27	Ordinary Shares	F	11541.00	$13.75	Disposed	426028.00	Direct
2026-02-28	Ordinary Shares	A	23818.00	$0.00	Acquired	449846.00	Direct
2026-03-02	Ordinary Shares	F	2410.00	$13.67	Disposed	447436.00	Direct
2026-03-02	Ordinary Shares	F	7228.00	$13.67	Disposed	440208.00	Direct

Footnotes

F1: Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1).

F2: Represents vesting of performance-based restricted stock units.